Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma

Journal of Investigative Dermatology

Volumn 133, Issue 5, 2013, Pages 1188-1196

  Chren, Mary Margaret ^a,b   Linos, Eleni ^a   Torres, Jeanette S ^b,d   Stuart, Sarah E ^a   Parvataneni, Rupa ^a   Boscardin, W John ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Latino Health Access   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER SURGERY; CHEMOSURGERY; CURETTAGE; DESICCATION; FEMALE; FOLLOW UP; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SKIN CARCINOMA;

EID: 84876586267     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.403     Document Type: Article

References (29)

1. Bath-Hextall F, Bong J, Perkins W et al. (2004) Interventions for basal cell carcinoma of the skin: systematic review. BMJ 329:705
2. Charlson ME, Pompei PP, Ales KL et al. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373-83
3. Chren MM, Sahay AP, Bertenthal DS et al. (2007) Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol 127:1351-7
4. Chren MM, Sahay AP, Sands LP et al. (2004) Variation in care for non-melanoma skin cancer in a private practice and a Veterans Affairs clinic. Med Care 42:1019-26
5. Chren MM, Torres JS, Stuart SE et al. (2011) Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. Arch Dermatol 147:540-6
6. D'Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265-81
7. Do D (2009) Mohs micrographic surgery for basal cell carcinoma of the face. Arch Dermatol 145:1428-30
8. Essers BA, Dirksen CD, Nieman FH et al. (2006) Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol 142:187-94
9. Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348:1681-91
10. Feldman S, Pearce DJ, Williford PM (2008) Surgical decision making for basal-cell carcinoma of the face. Lancet Oncol 9:1119-20
11. Fitzpatrick TB (1988) The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124:869-71
12. Hausauer AK, Maurer T, Leslie KS et al. Recurrence after treatment of cutaneous basal cell and squamous cell carcinomas in patients infected with human immunodeficiency virus. Arch Dermatol (in press)
13. Jasjeet SS (2011) Multivariate and propensity score matching software with automated balance optimization: the matching package for R. J Stat Soft 42:1-52
14. Katz JN, Chang LC, Sangha O et al. (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73-84
15. McGovern TW, Leffell DJ (1999) Mohs surgery: the informed view. Arch Dermatol 135:1255-9
16. Mosterd K, Krekels GA, Nieman FH et al. (2008) Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 9:1149-56
17. NCCN (2011) Basal cell and squamous cell skin cancers. In: National Comprehensive Cancer Network. The complete Library of NCCN Clinical Practice Guidelines in Oncology, version 1. 2012
18. Otley CC (2005) Mohs' micrographic surgery for basal-cell carcinoma of the face. Lancet 365:1226-7
19. Otley CC (2006) Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol 142:1235
20. Rogers HW, Weinstock MA, Harris AR et al. (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146:283-7
21. Rubin DB (1997) Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127:757-63
22. Shuster S (1999) The case against micrographically controlled skin surgery. Acta Derm Venereol 79:2-3
23. Smeets NW, Kuijpers DI, Nelemans P et al. (2004) Mohs' micrographic surgery for treatment of basal cell carcinoma of the face-results of a retrospective study and review of the literature. Br J Dermatol 151:141-7
24. Swanson NA, Grekin RC, Baker SR (1983) Mohs surgery: techniques, indications, and applications in head and neck surgery. Head Neck Surg 6:683-92
25. Tinetti ME, Studenski SA (2011) Comparative effectiveness research and patients with multiple chronic conditions. N Engl J Med 364:2478-81
26. Viola KV, Jhaveri MB, Soulos PR et al. (2012) Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the medicare population. Arch Dermatol 148:473-7
27. Ware J Jr, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220-33
28. Williford PM, Feldman SR (2004) Surgery for basal-cell carcinoma of the face. Lancet 364:1732-3
29. Wilson LS, Pregenzer M, Basu R et al. (2012) Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg 38:570-84